249 / 264
Selected Section Materials by Author
I - 4
Reiter R, Pickhard A, Sander S, Brosch S. Prognostic relevance of mucosal waves in patients with unilateral
vocal fold paralysis.
Ann Otol Rhinol Laryngol
. 2016; 125(4):331-335. EBM level 4
Richards AL, Sugumaran M, Aviv JE, et al. The utility of office-based biopsy for laryngopharyngeal lesions:
comparison with surgical evaluation.
Laryngoscope
. 2015; 125(4):909-912. EBM level 4
Rosow DE, Sulica L. Laryngoscopy of vocal fold paralysis: evaluation of consistency of clinical findings.
Laryngoscope
. 2010; 120(7):1376-1382. EBM level 2
Simpson CB, May LS, Green JK, et al. Vibratory asymmetry in mobile vocal folds: is it predictive of vocal fold
paresis?
Ann Otol Rhinol Laryngol
. 2011; 120(4):239-242. EBM level 4
Spataro EA, Grindler DJ, Paniello RC. Etiology and time to presentation of unilateral vocal fold paralysis.
Otolaryngol Head Neck Surg
. 2014; 151(2):286-293. EBM level 4
Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Clinical manifestations and treatment of idiopathic
and Wegener granulomatosis-associated subglottic stenosis.
JAMA Otolaryngol Head Neck Surg
. 2013;
139(1):76-81. EBM level 4
Verma SP, Dailey SH. Office-based injection laryngoplasty for the management of unilateral vocal fold
paralysis.
J Voice
. 2014; 28(3):382-386. EBM level 4
Wu AP, Sulica L. Diagnosis of vocal fold paresis: current opinion and practice.
Laryngoscope
. 2015;
125(4):904-908. EBM level 5
Yamauchi A, Yokonishi H, Imagawa H, et al. Vocal fold vibration in vocal fold atrophy: quantitative analysis
with high-speed digital imaging.
J Voice
. 2015; 29(6):755-762. EBM level 2
Youssef TF, Ahmed MR. Treatment of clinically diagnosed laryngopharyngeal reflux disease.
Arch
Otolaryngol Head Neck Surg
. 2010; 136(11):1089-1092. EBM level 1
Zeigler A, Verdolini Abbott K, Johns M, et al. Preliminary data on two voice therapy interventions in the
treatment of presbyphonia.
Laryngoscope
. 2014; 124(8):1869-1876. EBM level 2b
Section 7: Neoplastic and Inflammatory Diseases of the Head and Neck
Agrawal A, Civantos FJ, Brumund KT, et al. [
(99m)
Tc]Tilmanocept accurately detects sentinel lymph nodes and
predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a
phase III multi-institutional trial.
Ann Surg Oncol
. 2015; 22(11):3708-3715. EBM level 1
Andtbacka RH, Agarwala SS, Ollila DW, et al. Cutaneous head and neck melanoma in OPTiM, a randomized
phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the
treatment of unresected stage IIIB/IIIC/IV melanoma.
Head Neck
. 2016; 38(12):1752-1758. EBM level 2
Badran K, Jani P, Berman L. Otolaryngologist-performed head and neck ultrasound: outcomes and challenges
in learning the technique.
J Laryngol Otol
. 2014; 128(5):447-453. EBM level 3
Busch EL, Zevallos JP, Olshan AF. Gastroesophageal reflux disease and odds of head and neck squamous cell
carcinoma in North Carolina.
Laryngoscope
. 2016; 126(5):1091-1096. EBM level 3